Integra LifeSciences Holdings (IART)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 1,608,880 | 1,486,360 | 1,506,670 | 1,533,950 | 1,298,690 |
| Property, plant and equipment | US$ in thousands | 405,723 | 340,199 | 311,302 | 311,703 | 287,529 |
| Fixed asset turnover | 3.97 | 4.37 | 4.84 | 4.92 | 4.52 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $1,608,880K ÷ $405,723K
= 3.97
Integra LifeSciences Holdings' fixed asset turnover ratio has shown a generally positive trend over the past five years, ranging from 3.97 to 4.92. This ratio indicates that the company generated between $3.97 and $4.92 in sales revenue for every dollar invested in fixed assets during the respective fiscal years. The increasing trend from 2020 to 2021 suggests that the company's efficiency in utilizing its fixed assets to generate sales improved. However, there was a slight decline in 2023, followed by a more significant decrease in 2024. This decreasing trend may indicate potential inefficiencies in asset utilization or changes in the company's operations that affected its revenue generation relative to its fixed asset base. Further analysis of the underlying factors contributing to this decline would be necessary to assess the overall impact on Integra LifeSciences' financial performance and operational efficiency.
Peer comparison
Dec 31, 2024